B
REGN icon

Barings’s Regeneron Pharmaceuticals REGN Stock Holding History

Barings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-629
Closed -$351K – 427
2021
Q2 		$351K Sell
629
-54
-8% -$27.4K 0.01% 339
2021
Q1 		$323K Buy
683
+17
+3% +$8.28K 0.01% 361
2020
Q4 		$322K Sell
666
-5,252
-89% -$2.84M 0.01% 339
2020
Q3 		$3.31M Buy
5,918
+2,762
+88% +$1.67M 0.08% 180
2020
Q2 		$1.54M Hold
3,156
– – 0.05% 225
2020
Q1 		$1.54M Sell
3,156
-439
-12% -$181K 0.05% 225
2019
Q4 		$1.34M Sell
3,595
-670
-16% -$225K 0.04% 308
2019
Q3 		$1.18M Buy
4,265
+1
+0% +$296 0.03% 341
2019
Q2 		$1.33M Buy
4,264
+157
+4% +$52.3K 0.03% 331
2019
Q1 		$1.69M Buy
4,107
+2,380
+138% +$980K 0.04% 311
2018
Q4 		$645K Hold
1,727
– – 0.01% 451
2018
Q3 		$698K Hold
1,727
– – 0.01% 553
2018
Q2 		$596K Buy
+1,727
New +$540K 0.01% 604
2016
Q1 		– Sell
-710
Closed -$385K – 968
2015
Q4 		$385K Hold
710
– – 0.01% 719
2015
Q3 		$330K Sell
710
-620
-47% -$333K 0.01% 736
2015
Q2 		$678K Sell
1,330
-1,660
-56% -$810K 0.02% 617
2015
Q1 		$1.35M Buy
2,990
+2,040
+215% +$865K 0.03% 426
2014
Q4 		$390K Hold
950
– – 0.01% 726
2014
Q3 		$342K Hold
950
– – 0.01% 762
2014
Q2 		$268K Hold
950
– – 0.01% 864
2014
Q1 		$285K Hold
950
– – 0.01% 806
2013
Q4 		$261K Hold
950
– – 0.01% 791
2013
Q3 		$297K Buy
+950
New +$250K 0.01% 765

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Barings's REGN Position: Q3 2021 in Review

Barings sold out of Regeneron Pharmaceuticals (REGN) in Q3 2021, closing a stake of 629 shares — an estimated $351K sold.

Barings first reported a position in REGN in Q3 2013 and held it in 23 quarters. The position peaked at $3.31M in Q3 2020. 1,019 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

  • Barings reported no remaining Regeneron Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Barings sold 629 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $351K.
  • Barings first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 23 quarters.
  • Barings's Regeneron Pharmaceuticals position peaked at $3.31M in Q3 2020.
  • 1,019 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Barings's 13F filing for Q3 2021, filed 12 Nov 2021.